
Lupin Limited has informed the Exchange about press release dated 09-Dec-2022 titled Lupin Launches Authorized Generic Version of PENNSAID�� 2% w/w in the United States.
Filed with NSE ·

Lupin Limited has informed the Exchange about press release dated 09-Dec-2022 titled Lupin Launches Authorized Generic Version of PENNSAID�� 2% w/w in the United States.
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin